Digital Health

Practices

• Corporate
  700+

  digital health companies represented by Cooley as they improve the quality and affordability of healthcare

  1,600+

  private financings handled annually, with $9.2 billion in aggregate digital health transactions in 2024

  #1

  IPO firm for 15 years, representing more VC-backed initial public offerings than any other firm, according to IPO Vital Signs

  30%

  Nearly a third of US-based unicorns are represented by Cooley

  Access to an unparalleled network of active digital health investors and thought leaders

  Lawyers who are widely recognized for thought leadership in the digital health space, including delivery of keynotes for the BIO International Convention’s digital health and artificial intelligence (AI) tracks and the Digital Health Innovation Summit Litigation

  Read more
• Litigation
  85+

  trials and arbitrations across global venues in the past 10 years

  100+

  venues argued before, including state, federal and international courts, arbitral forums and administrative bodies

  5

  Fellows of the American College of Trial Lawyers and 20+ former assistant US attorneys and Department of Justice lawyers within our team

  60+

  mentions in The American Lawyer’s Litigation Daily Litigator of the Week since 2022

  Frequently litigating landmark, precedent-setting cases that establish industrywide resolutions or new procedural protections for our clients

  Defending clients against False Claims Act actions arising from allegations of billing/coding misconduct, patient safety and research misconduct, manufacturing deficiencies and other Food, Drug, and Cosmetic Act violations, drug pricing misconduct, federal and state anti-kickback law violations, and other relevant fraud and abuse laws led by local, state, and federal civil and criminal government enforcers

  Read more
• Regulatory
  Leveraging strong US and global experience to provide regulatory counseling and advice on the Food and Drug Administration, fraud and abuse, corporate compliance, contractual relationships, transparency and “sunshine” laws, government program price reporting programs, healthcare data privacy and protection, licensure, accreditation, corporate practice of medicine, health reform counseling, regulatory due diligences, the UK Medicines and Healthcare Regulatory Agency (MHRA) and CE marking

  Advising all players in the evolving ecosystem, including healthtech, health artificial intelligence (AI), population health management, health and wellness, payers, providers, life sciences companies, health IT and investors

  Serving as connectors to the digital health ecosystem who counsel clients on how to launch innovative products and services

  Using vast subject matter knowledge and litigation and negotiation experience to represent healthcare clients in connection with federal and state government investigations, inquiries, settlements, and voluntary disclosures

  Offering a multidisciplinary team of industry-leading lawyers who provide counsel related to privacy and data protection, government contracts, and government analytics

  Contributing frequently on groundbreaking regulatory topics at high-profile industry events, on editorial boards, and in relevant media and publications

  Market leader in life sciences – #1 in IPOs, M&A transactions, venture financings and licensing

  Providing comprehensive and timely guidance through CooleyREG, our innovative approach that brings together regulatory practitioners from across the firm to help clients navigate every regulatory twist and turn

  Read more
• Intellectual Property
  1,000+

  investor-side and company-side patent due diligence reviews in M&A deals, capital market offerings, financings and other high-value transactions

  450+

  US patent, trademark and copyright district court cases handled since 2019

  70,000+

  patents and trademarks under Cooley management globally

  Read more